Avicenna Biosciences, Inc. research brief
CIK 1824034
Generated Nov. 17, 2026, 7:48 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: DURHAM North Carolina. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Oct. 30, 2025 · D/A · 0001824034-25-000002 · Source evidence
Reported offering amount: 70650 USD. Reported amount sold: 70650 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Avicenna Biosciences, Inc. research brief,” CIK 1824034, retrieved Nov. 17, 2026, 7:48 p.m.. Cite the specific accessions used. No amounts have been summed.